Gleiss Lutz advises Zur Rose Group on the establishment of the Doc Morris Adipositas Care portal

A Gleiss Lutz team advised the Zur Rose Group on the establishment of the Doc Morris Adipositas Care portal. The Zur Rose Group already reaches 9.8 million active customers across online pharmacy, marketplace and telemedical platforms in Europe, particularly under the well-known Doc Morris brand.

Doc Morris Adipositas Care opens up a comprehensive new information offering on dealing with the disease of obesity. It also offers the opportunity to receive specialised telemedical advice and treatment through partner TeleClinic and makes using new digital obesity therapies such as the zanadio and Selfapy apps "just a click away". The new portal therefore plays a leading role in the area of digital treatment methods for obesity patients.

The following Gleiss Lutz team provided IP/IT, antitrust and contracts advice on the contracts and the specific design of the portal and on healthcare compliance: Dr. Alexander Molle (partner, IP/IT), Dr. Enno Burk (counsel, both lead, both Berlin), Dr. Marco König (partner, Stuttgart, both healthcare ), Dr. Matthias Schilde, Dr. Felix Müller (all IP/IT, Berlin), Dr. Moritz Holm-Hadulla (partner), Dr. Dominik Braun (both Competition/Antitrust, Stuttgart).

Gleiss Lutz conducted the negotiations about developing the portal with a team from Swiss firm Walder Wyss, Zurich.